Haibo Wang
- Cancer Research top 5%
- Oncology top 5%
- Cancer Cells and Metastasis 15
- HER2/EGFR in Cancer Research 11
- Hepatology top 5%
- Molecular Medicine top 5%
-
- Natural Compounds in Disease Treatment 25
-
- Natural product bioactivities and synthesis 17
- Ubiquitin and proteasome pathways 8
-
- Gastric Cancer Management and Outcomes 9
- Advanced Breast Cancer Therapies 9
- Ferroptosis and cancer prognosis 8
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Haibo Wang
159 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 486
- Oncology 677
- Hepatology 196
- Molecular Medicine 95
- Complementary and alternative medicine 154
Countries citing papers authored by Haibo Wang
This map shows the geographic impact of Haibo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Wang more than expected).
Fields of papers citing papers by Haibo Wang
This network shows the impact of papers produced by Haibo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Wang. The network helps show where Haibo Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haibo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 1 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 16 | |
| 16 | Research on effect of Celastrus orbiculatus extract on inhibiting invasion and metastasis of human gastric cancer SGC-7901 cells by mediating matrix metalloproteinases group and their inhibitors | 2016 | 1 |
| 17 | Relationship Between HSP70 and ERBB2 Expression in Breast Cancer Cell Lines Regarding Drug Resistance. | 2016 | 8 |
| 18 | 2015 | 15 | |
| 19 | 2012 | 1 | |
| 20 | Genetic Transformation of Wheat (Triticum aestivum L): A Review | 2004 | 6 |
About Haibo Wang
Haibo Wang is a scholar working on Complementary and alternative medicine, Oncology and Pharmacology, having authored 165 papers that have together received 2.5k indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (25 papers), Natural product bioactivities and synthesis (17 papers), Cancer Cells and Metastasis (15 papers), HER2/EGFR in Cancer Research (11 papers), Gastric Cancer Management and Outcomes (9 papers), Advanced Breast Cancer Therapies (9 papers), Ubiquitin and proteasome pathways (8 papers) and Ferroptosis and cancer prognosis (8 papers). The work is most often cited by research in Cancer Research (486 citations), Oncology (677 citations) and Hepatology (196 citations). Haibo Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yanqing Liu, Xiangping Liu, Yayun Qian, Zhi‐Dong Lv, Tengyang Ni, Weihong Cao, Xiaoyi Liu, Funian Li, Weijun Zhao and Shiyu Guo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.